Lonza 

Small Molecule Capabilities  

At Lonza Pharma & Biotech, we provide development and manufacturing services that enable biopharma companies to bring small molecule medicines to patients in need.  

From drug substance to the final drug product, our solutions feature enabling technologies to successful advance your molecule, and concept to commercial services to simplify your outsourcing experience.  Our extensive track record includes development and manufacture across a wide range of drug substances, particle-engineered intermediates and specialized drug products for oral solid, parenteral and inhaled delivery routes. We continuously invest to solve not just current, but also future challenges that support the development and commercialization of pioneering therapies.  

Together, we can bring your next medicine to life. 

Services Overview 

Lonza is an industry-leading integrated development and manufacturing service provider for small molecule drugs and their intermediates. We support drug programs from pre-clinical development through to commercialization and our extensive service portfolio covers the continuum of drug substance to drug product.    We specialize in key areas critical to advancing today’s molecules: highly potent API, bioavailability challenges, particle engineering, and specialized drug delivery.  Our integrated capacity enables you to collaborate with a single service provider for a wide variety of service needs designed to accelerate timelines, simplify the outsourcing experience, and minimize program risk and cost. 

Technical Services 

Our service portfolio is comprehensive and flexible, allowing us to provide a cost-phase-appropriate package that suits your business needs. The following services serve as examples:  

• SimpliFiH® Solutions - an integrated First-in Human service package  
• Development and production of  drug substance and drug product intermediates 
• High potency drug substance and drug product manufacturing 
• Antibody Drug Conjugate payload development and manufacturing 
• Solubility and bioavailability improvement 

• Oral, parenteral, and inhalation formulation development 
• Modified and targeted delivery  
• Analytical method development and validation 
• Regulatory consulting 
• Lifecycle management 

• Scale-up and tech transfer 

Facilities 

We have contract development and manufacturing services for drug substance, particle engineered intermediates and drug products around the globe. Our major development and manufacturing sites are located in Switzerland, United Kingdom, France, USA and China.  In addition, we have local sales offices in other countries to enable close communication with you. 

Markets Served 

We serve pharmaceutical and biopharmaceutical companies globally, striving to provide technologies, services and expertise to ensure successful outcomes and help reduce capital risk.  Our customers range in size from small, even virtual companies, to some of the world’s largest biopharmaceutical players.  The motivations for seeking a development and/or manufacturing partner will differ depending on company and business strategy. We work in close collaboration with you to ensure that we meet your specific requirements in each project.